A detailed history of Rhumbline Advisers transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Rhumbline Advisers holds 100,014 shares of SRRK stock, worth $3.77 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100,014
Previous 101,278 1.25%
Holding current value
$3.77 Million
Previous $843,000 4.98%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$7.63 - $9.71 $9,644 - $12,273
-1,264 Reduced 1.25%
100,014 $801,000
Q2 2024

Aug 01, 2024

BUY
$7.84 - $16.79 $56,620 - $121,257
7,222 Added 7.68%
101,278 $843,000
Q1 2024

May 09, 2024

BUY
$13.2 - $17.76 $56,839 - $76,474
4,306 Added 4.8%
94,056 $1.67 Million
Q4 2023

Feb 08, 2024

BUY
$6.52 - $20.32 $170,576 - $531,611
26,162 Added 41.14%
89,750 $1.69 Million
Q3 2023

Nov 09, 2023

BUY
$6.02 - $7.76 $139,651 - $180,016
23,198 Added 57.44%
63,588 $451,000
Q2 2023

Aug 08, 2023

BUY
$5.79 - $9.11 $233,858 - $367,952
40,390 New
40,390 $304,000
Q2 2022

Aug 11, 2022

SELL
$4.66 - $13.96 $137,027 - $410,493
-29,405 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$11.89 - $24.68 $22,805 - $47,336
1,918 Added 6.98%
29,405 $379,000
Q4 2021

Feb 10, 2022

SELL
$24.14 - $35.18 $20,856 - $30,395
-864 Reduced 3.05%
27,487 $683,000
Q3 2021

Nov 12, 2021

BUY
$27.38 - $42.21 $34,033 - $52,467
1,243 Added 4.59%
28,351 $936,000
Q2 2021

Aug 05, 2021

BUY
$26.34 - $46.62 $39,589 - $70,069
1,503 Added 5.87%
27,108 $783,000
Q1 2021

May 06, 2021

SELL
$45.96 - $68.02 $72,111 - $106,723
-1,569 Reduced 5.77%
25,605 $1.3 Million
Q4 2020

Feb 10, 2021

BUY
$13.72 - $51.57 $65,005 - $244,338
4,738 Added 21.12%
27,174 $1.32 Million
Q3 2020

Nov 12, 2020

SELL
$10.54 - $18.47 $41,474 - $72,679
-3,935 Reduced 14.92%
22,436 $397,000
Q2 2020

Aug 13, 2020

BUY
$10.37 - $20.64 $59,575 - $118,576
5,745 Added 27.85%
26,371 $480,000
Q1 2020

May 06, 2020

BUY
$9.63 - $17.14 $4,092 - $7,284
425 Added 2.1%
20,626 $250,000
Q4 2019

Feb 05, 2020

BUY
$7.2 - $13.2 $4,665 - $8,553
648 Added 3.31%
20,201 $266,000
Q3 2019

Oct 23, 2019

BUY
$8.95 - $15.72 $3,490 - $6,130
390 Added 2.04%
19,553 $175,000
Q2 2019

Aug 14, 2019

BUY
$14.61 - $22.45 $35,458 - $54,486
2,427 Added 14.5%
19,163 $304,000
Q1 2019

May 01, 2019

BUY
$14.24 - $22.28 $238,320 - $372,878
16,736 New
16,736 $314,000

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $1.95B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.